National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

shark cartilage extract AE-941
A multifunctional antiangiogenic agent derived from shark cartilage with potential antineoplastic activity. Shark cartilage extract AE-941 competitively inhibits the binding of pro-angiogenic vascular endothelial growth factor (VEGF) to its cell receptor, thereby inhibiting endothelial cell proliferation. This agent also inhibits matrix metalloproteinases (MMPs), stimulates tissue plasminogen activator (tPA), and activates caspase-mediated apoptotic pathways in endothelial cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Neovastat/AE-941
US brand name:Neovastat
Foreign brand name:Neovastat
Code name:AE-941



Previous:Seromycin, Serophene, sertraline hydrochloride, sevoflurane, shark cartilage
Next:sialyl LewisÂȘ-keyhole limpet hemocyanin conjugate vaccine, Sigosix, sildenafil citrate, silicon phthalocyanine 4, Silybin-Phytosome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov